| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by investing activities | 43,228 | 25,344 |
| Proceeds from issuance of common stock | 14 | 14 |
| Net cash provided by financing activities | 14 | 14 |
| Net increase (decrease) in cash | 10,548 | 2,396 |
| Cash and cash equivalents at beginning of period | 8,970 | - |
| Cash and cash equivalents at end of period | 19,518 | - |
Bolt Biotherapeutics, Inc. (BOLT)
Bolt Biotherapeutics, Inc. (BOLT)